ENZ - Enzo Biochem, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
7/30/2019
7/30/2018
7/30/2017
7/30/2016
Total Revenue
80,117
81,170
104,713
107,804
102,773
Cost of Revenue
58,204
57,922
60,385
59,478
57,190
Gross Profit
21,913
23,248
44,328
48,326
45,583
Operating Expenses
Research Development
3,501
3,175
3,210
2,928
3,524
Selling General and Administrative
47,829
47,265
49,592
45,689
49,970
Total Operating Expenses
51,330
50,440
56,492
51,392
55,830
Operating Income or Loss
-29,417
81,170
104,713
107,804
102,773
Interest Expense
-
-
-
-
136
Total Other Income/Expenses Net
29,220
28,625
-107
260
56,898
Income Before Tax
822
2,489
-11,418
-2,422
46,515
Income Tax Expense
0
0
-1,097
82
1,229
Income from Continuing Operations
822
2,489
-10,321
-2,504
45,286
Net Income
822
2,489
-10,321
-2,504
45,286
Net Income available to common shareholders
822
2,489
-10,321
-2,504
45,286
Reported EPS
Basic
-
0.05
-0.22
-0.05
0.98
Diluted
-
0.05
-0.22
-0.05
0.97
Weighted average shares outstanding
Basic
-
47,351
46,972
46,351
46,153
Diluted
-
47,476
46,972
46,351
46,602
EBITDA
-
81,170
104,713
107,804
102,773